Feed excerpt — reported by STAT News
People with schizophrenia who were taking GLP-1 drugs for diabetes had fewer psychiatric relapses in a large study of U.S. health records.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →